| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross margin | 271,4 k € | +32.0% | 205,5 k € | +15.5% | 177,9 k € | +21.6% | 146,3 k € | -16.4% | 175,0 k € | +55.5% | 112,5 k € | -32.5% | 166,6 k € | -17.0% | 200,8 k € | +52.1% | 132,0 k € | -36.1% | 206,5 k € | -28.1% | 287,3 k € | |
| EBITDA | 270,2 k € | +34.2% | 201,3 k € | +13.8% | 176,8 k € | +21.9% | 145,1 k € | -16.6% | 174,0 k € | +55.8% | 111,6 k € | -32.6% | 165,7 k € | -17.0% | 199,7 k € | +52.5% | 131,0 k € | -36.2% | 205,3 k € | -28.2% | 285,9 k € | |
| Operating profit | 269,7 k € | +62.3% | 166,2 k € | +17.3% | 141,7 k € | +28.9% | 110,0 k € | -20.8% | 138,9 k € | +81.5% | 76,5 k € | -37.7% | 122,9 k € | -21.7% | 156,9 k € | +77.9% | 88,2 k € | -45.7% | 162,5 k € | -33.2% | 243,0 k € | |
| Profit/loss | 205,8 k € | +59.9% | 128,7 k € | +24.6% | 103,3 k € | +25.7% | 82,2 k € | -21.3% | 104,4 k € | +83.4% | 56,9 k € | -37.6% | 91,2 k € | -20.6% | 114,9 k € | +101.0% | 57,2 k € | -47.6% | 109,1 k € | -31.9% | 160,1 k € | |
| Equity | 18,6 k € | -75.7% | 76,5 k € | -61.3% | 197,8 k € | +1.7% | 194,5 k € | -37.7% | 312,4 k € | +50.2% | 208,0 k € | +37.7% | 151,1 k € | -67.1% | 459,9 k € | +33.3% | 345,0 k € | +19.9% | 287,8 k € | +61.0% | 178,7 k € | |
| Total assets | 266,2 k € | +17.4% | 226,7 k € | -52.0% | 472,4 k € | +21.3% | 389,4 k € | -14.2% | 454,1 k € | +35.7% | 334,6 k € | -44.9% | 607,2 k € | +4.6% | 580,3 k € | +12.8% | 514,2 k € | +9.5% | 469,5 k € | -22.9% | 609,2 k € | |
| Cash | 120,0 k € | +538.5% | 18,8 k € | -94.6% | 347,1 k € | +37.4% | 252,7 k € | -18.3% | 309,4 k € | +121.1% | 139,9 k € | -59.6% | 346,1 k € | +21.1% | 285,8 k € | +52.0% | 188,0 k € | +92.4% | 97,7 k € | -46.6% | 182,9 k € | |
| Debts | 247,6 k € | +64.8% | 150,2 k € | -45.2% | 273,9 k € | +41.4% | 193,7 k € | +36.7% | 141,7 k € | +12.0% | 126,6 k € | -72.2% | 455,3 k € | +278.3% | 120,3 k € | -28.8% | 169,0 k € | -6.9% | 181,4 k € | -57.8% | 430,4 k € | |
Private limited company · Hove · incorporated on 10/03/2015
Private limited company profitable but thinly capitalised. Cash position rising (+538.5%).
Acceptable counterparty for a moderate engagement. Require 2 fiscal years of detailed accounts before any significant exposure — thin equity (18,6 k €) relative to earnings. The abridged model hides revenue.
Dr. Jeroen Lenz is a Private limited company incorporated in 2015. Its main activity is: Specialist medical practice activities. Its registered office is in Hove.
Key indicators
7-day free trial, no credit card required.
7-day free trial, no credit card required.
7-day free trial, no credit card required.
Source: Belgian Official Gazette